GHRL and Cirrhosis: Some clinical studies had further proposed that Ghrelin could be considered a non-invasive diagnostic marker for patients with chronic liver disease to progress to cirrhosis, pointing out that serum Ghrelin levels below 850 pg/mL could be considered to progress to cirrhosis from chronic liver diseases, and those below 440 pg/mL, progression to decompensated cirrhosis might be considered (Elaghori et al., 2019).